American Society of Clinical Oncology Statement: Human Papillomavirus Vaccination for Cancer Prevention

American Society of Clinical Oncology (ASCO), the leading medical professional oncology society, is committed to lessening the burden of cancer and as such will promote underused interventions that have the potential to save millions of lives through cancer prevention. As the main providers of cance...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical oncology Vol. 34; no. 15; p. 1803
Main Authors: Bailey, Howard H, Chuang, Linus T, duPont, Nefertiti C, Eng, Cathy, Foxhall, Lewis E, Merrill, Janette K, Wollins, Dana S, Blanke, Charles D
Format: Journal Article
Language:English
Published: United States 20.05.2016
Subjects:
Female
Humans
Medical Oncology
Papillomavirus Vaccines - adverse effects
Papillomavirus Vaccines - immunology
Physician's Role
Societies, Medical
Uterine Cervical Neoplasms - prevention & control
Vaccination
ISSN:1527-7755, 1527-7755
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract American Society of Clinical Oncology (ASCO), the leading medical professional oncology society, is committed to lessening the burden of cancer and as such will promote underused interventions that have the potential to save millions of lives through cancer prevention. As the main providers of cancer care worldwide, our patients, their families, and our communities look to us for guidance regarding all things cancer related, including cancer prevention. Through this statement and accompanying recommendations, ASCO hopes to increase awareness of the tremendous global impact of human papillomavirus (HPV) -caused cancers, refocus the discussion of HPV vaccination on its likely ability to prevent millions of cancer deaths, and increase HPV vaccination uptake via greater involvement of oncology professionals in ensuring accurate public discourse about HPV vaccination and calling for the implementation of concrete strategies to address barriers to vaccine access and acceptance.
AbstractList American Society of Clinical Oncology (ASCO), the leading medical professional oncology society, is committed to lessening the burden of cancer and as such will promote underused interventions that have the potential to save millions of lives through cancer prevention. As the main providers of cancer care worldwide, our patients, their families, and our communities look to us for guidance regarding all things cancer related, including cancer prevention. Through this statement and accompanying recommendations, ASCO hopes to increase awareness of the tremendous global impact of human papillomavirus (HPV) -caused cancers, refocus the discussion of HPV vaccination on its likely ability to prevent millions of cancer deaths, and increase HPV vaccination uptake via greater involvement of oncology professionals in ensuring accurate public discourse about HPV vaccination and calling for the implementation of concrete strategies to address barriers to vaccine access and acceptance.American Society of Clinical Oncology (ASCO), the leading medical professional oncology society, is committed to lessening the burden of cancer and as such will promote underused interventions that have the potential to save millions of lives through cancer prevention. As the main providers of cancer care worldwide, our patients, their families, and our communities look to us for guidance regarding all things cancer related, including cancer prevention. Through this statement and accompanying recommendations, ASCO hopes to increase awareness of the tremendous global impact of human papillomavirus (HPV) -caused cancers, refocus the discussion of HPV vaccination on its likely ability to prevent millions of cancer deaths, and increase HPV vaccination uptake via greater involvement of oncology professionals in ensuring accurate public discourse about HPV vaccination and calling for the implementation of concrete strategies to address barriers to vaccine access and acceptance.
American Society of Clinical Oncology (ASCO), the leading medical professional oncology society, is committed to lessening the burden of cancer and as such will promote underused interventions that have the potential to save millions of lives through cancer prevention. As the main providers of cancer care worldwide, our patients, their families, and our communities look to us for guidance regarding all things cancer related, including cancer prevention. Through this statement and accompanying recommendations, ASCO hopes to increase awareness of the tremendous global impact of human papillomavirus (HPV) -caused cancers, refocus the discussion of HPV vaccination on its likely ability to prevent millions of cancer deaths, and increase HPV vaccination uptake via greater involvement of oncology professionals in ensuring accurate public discourse about HPV vaccination and calling for the implementation of concrete strategies to address barriers to vaccine access and acceptance.
Author Wollins, Dana S
Eng, Cathy
duPont, Nefertiti C
Foxhall, Lewis E
Blanke, Charles D
Chuang, Linus T
Bailey, Howard H
Merrill, Janette K
Author_xml – sequence: 1
  givenname: Howard H
  surname: Bailey
  fullname: Bailey, Howard H
  email: hhb@medicine.wisc.edu
  organization: Howard H. Bailey, University of Wisconsin Carbone Cancer Center, Madison, WI; Linus T. Chuang, Mount Sinai School of Medicine, New York, NY; Nefertiti C. duPont, Gynecologic Surgeons of North Houston, Shenandoah; Cathy Eng and Lewis E. Foxhall, MD Anderson Cancer Center, Houston, TX; Janette K. Merrill and Dana S. Wollins, American Society of Clinical Oncology, Alexandria, VA; and Charles D. Blanke, Oregon Health and Science University, Portland, OR. hhb@medicine.wisc.edu
– sequence: 2
  givenname: Linus T
  surname: Chuang
  fullname: Chuang, Linus T
  organization: Howard H. Bailey, University of Wisconsin Carbone Cancer Center, Madison, WI; Linus T. Chuang, Mount Sinai School of Medicine, New York, NY; Nefertiti C. duPont, Gynecologic Surgeons of North Houston, Shenandoah; Cathy Eng and Lewis E. Foxhall, MD Anderson Cancer Center, Houston, TX; Janette K. Merrill and Dana S. Wollins, American Society of Clinical Oncology, Alexandria, VA; and Charles D. Blanke, Oregon Health and Science University, Portland, OR
– sequence: 3
  givenname: Nefertiti C
  surname: duPont
  fullname: duPont, Nefertiti C
  organization: Howard H. Bailey, University of Wisconsin Carbone Cancer Center, Madison, WI; Linus T. Chuang, Mount Sinai School of Medicine, New York, NY; Nefertiti C. duPont, Gynecologic Surgeons of North Houston, Shenandoah; Cathy Eng and Lewis E. Foxhall, MD Anderson Cancer Center, Houston, TX; Janette K. Merrill and Dana S. Wollins, American Society of Clinical Oncology, Alexandria, VA; and Charles D. Blanke, Oregon Health and Science University, Portland, OR
– sequence: 4
  givenname: Cathy
  surname: Eng
  fullname: Eng, Cathy
  organization: Howard H. Bailey, University of Wisconsin Carbone Cancer Center, Madison, WI; Linus T. Chuang, Mount Sinai School of Medicine, New York, NY; Nefertiti C. duPont, Gynecologic Surgeons of North Houston, Shenandoah; Cathy Eng and Lewis E. Foxhall, MD Anderson Cancer Center, Houston, TX; Janette K. Merrill and Dana S. Wollins, American Society of Clinical Oncology, Alexandria, VA; and Charles D. Blanke, Oregon Health and Science University, Portland, OR
– sequence: 5
  givenname: Lewis E
  surname: Foxhall
  fullname: Foxhall, Lewis E
  organization: Howard H. Bailey, University of Wisconsin Carbone Cancer Center, Madison, WI; Linus T. Chuang, Mount Sinai School of Medicine, New York, NY; Nefertiti C. duPont, Gynecologic Surgeons of North Houston, Shenandoah; Cathy Eng and Lewis E. Foxhall, MD Anderson Cancer Center, Houston, TX; Janette K. Merrill and Dana S. Wollins, American Society of Clinical Oncology, Alexandria, VA; and Charles D. Blanke, Oregon Health and Science University, Portland, OR
– sequence: 6
  givenname: Janette K
  surname: Merrill
  fullname: Merrill, Janette K
  organization: Howard H. Bailey, University of Wisconsin Carbone Cancer Center, Madison, WI; Linus T. Chuang, Mount Sinai School of Medicine, New York, NY; Nefertiti C. duPont, Gynecologic Surgeons of North Houston, Shenandoah; Cathy Eng and Lewis E. Foxhall, MD Anderson Cancer Center, Houston, TX; Janette K. Merrill and Dana S. Wollins, American Society of Clinical Oncology, Alexandria, VA; and Charles D. Blanke, Oregon Health and Science University, Portland, OR
– sequence: 7
  givenname: Dana S
  surname: Wollins
  fullname: Wollins, Dana S
  organization: Howard H. Bailey, University of Wisconsin Carbone Cancer Center, Madison, WI; Linus T. Chuang, Mount Sinai School of Medicine, New York, NY; Nefertiti C. duPont, Gynecologic Surgeons of North Houston, Shenandoah; Cathy Eng and Lewis E. Foxhall, MD Anderson Cancer Center, Houston, TX; Janette K. Merrill and Dana S. Wollins, American Society of Clinical Oncology, Alexandria, VA; and Charles D. Blanke, Oregon Health and Science University, Portland, OR
– sequence: 8
  givenname: Charles D
  surname: Blanke
  fullname: Blanke, Charles D
  organization: Howard H. Bailey, University of Wisconsin Carbone Cancer Center, Madison, WI; Linus T. Chuang, Mount Sinai School of Medicine, New York, NY; Nefertiti C. duPont, Gynecologic Surgeons of North Houston, Shenandoah; Cathy Eng and Lewis E. Foxhall, MD Anderson Cancer Center, Houston, TX; Janette K. Merrill and Dana S. Wollins, American Society of Clinical Oncology, Alexandria, VA; and Charles D. Blanke, Oregon Health and Science University, Portland, OR
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27069078$$D View this record in MEDLINE/PubMed
BookMark eNpNkL1PwzAUxC1URD9gZ0IeWVIcp7ZjtiriU5VaqcAavThOZeTYxXEq9b8niCIx3dPd791wUzRy3mmErlMyTykhd6_Fek5Jyudc_OjiDE1SRkUiBGOjf_cYTbvukwxEnrELNKaCcElEPkG7ZauDUeDw1iuj4xH7BhfWuMGzeO2Ut353xNsIUbfaxXv83LcDvYG9sda3cDCh7_AHKGUcROMdbnzABTilA94EfRieBvcSnTdgO3110hl6f3x4K56T1frppViuEkWljAnUKWNZRqqG1EQKUVWgSM4ZbaSuagBeV4zmjDPgnENaE8iZFpoMuZQLSukM3f727oP_6nUXy9Z0SlsLTvu-K1ORS5ItBM8G9OaE9lWr63IfTAvhWP6NQ78B-SlpPQ
CitedBy_id crossref_primary_10_1016_j_rce_2017_07_011
crossref_primary_10_1093_milmed_usz403
crossref_primary_10_1186_s12887_022_03562_1
crossref_primary_10_1177_2165079917712528
crossref_primary_10_2298_MPNS2208224R
crossref_primary_10_1016_j_oraloncology_2017_09_015
crossref_primary_10_1016_j_ajog_2017_08_109
crossref_primary_10_1016_j_vaccine_2016_11_012
crossref_primary_10_1007_s11042_021_10627_3
crossref_primary_10_1111_jog_13929
crossref_primary_10_1200_JGO_18_00074
crossref_primary_10_1016_j_rceng_2017_10_001
crossref_primary_10_1080_14760584_2017_1383158
crossref_primary_10_1186_s12889_018_5958_8
crossref_primary_10_1002_smtd_202402059
crossref_primary_10_1186_s12889_020_08561_4
crossref_primary_10_1016_j_ajog_2016_10_006
crossref_primary_10_1080_13557858_2018_1514452
crossref_primary_10_1186_s12912_023_01522_3
crossref_primary_10_1073_pnas_1608077113
crossref_primary_10_1016_j_medcle_2018_04_012
crossref_primary_10_1200_GO_22_00410
crossref_primary_10_1007_s11764_023_01391_4
crossref_primary_10_1016_j_critrevonc_2020_103111
crossref_primary_10_1158_1940_6207_CAPR_18_0421
crossref_primary_10_1200_JCO_2017_74_1843
crossref_primary_10_1016_j_gore_2017_08_004
crossref_primary_10_1200_GO_20_00286
crossref_primary_10_1097_OR9_0000000000000068
crossref_primary_10_1007_s10989_017_9641_1
crossref_primary_10_1016_j_eswa_2018_08_050
crossref_primary_10_1007_s13193_018_0842_7
crossref_primary_10_1016_j_ypmed_2018_01_016
crossref_primary_10_1016_j_techfore_2020_120375
crossref_primary_10_1016_j_jnma_2019_06_004
crossref_primary_10_2217_fvl_2020_0014
crossref_primary_10_1007_s10903_023_01537_7
crossref_primary_10_1097_MD_0000000000016991
crossref_primary_10_1016_j_ygyno_2017_11_037
crossref_primary_10_1016_j_jons_2018_04_002
crossref_primary_10_1007_s13669_017_0216_0
crossref_primary_10_1016_j_puhip_2021_100079
crossref_primary_10_1590_1806_9282_2023s120
crossref_primary_10_1080_08941939_2019_1683658
crossref_primary_10_1016_j_vaccine_2017_03_093
crossref_primary_10_2478_FON_2019_0048
crossref_primary_10_1089_jayao_2017_0014
crossref_primary_10_1016_S1473_3099_18_30600_5
crossref_primary_10_1016_j_vaccine_2024_126417
crossref_primary_10_1038_s41568_024_00744_0
crossref_primary_10_1016_j_ajog_2017_02_026
crossref_primary_10_1200_JGO_2016_008151
ContentType Journal Article
Copyright 2016 by American Society of Clinical Oncology.
Copyright_xml – notice: 2016 by American Society of Clinical Oncology.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1200/JCO.2016.67.2014
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1527-7755
ExternalDocumentID 27069078
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: UG1 CA189974
GroupedDBID ---
.55
0R~
18M
2WC
34G
39C
4.4
53G
5GY
5RE
8F7
AAQOH
AARDX
AAWTL
AAYEP
ABBLC
ABJNI
ABOCM
ACGFO
ACGFS
ACGUR
ADBBV
AEGXH
AENEX
AIAGR
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BYPQX
C45
CGR
CS3
CUY
CVF
DIK
EBS
ECM
EIF
EJD
F5P
F9R
FBNNL
FD8
GX1
H13
HZ~
IH2
K-O
KQ8
L7B
LSO
MJL
N9A
NPM
O9-
OK1
OVD
OWW
P2P
QTD
R1G
RHI
RLZ
RUC
SJN
TEORI
TR2
TWZ
UDS
VVN
WH7
X7M
YFH
YQY
7X8
ID FETCH-LOGICAL-c299t-ad155330bf0d0977bbac08652f9ebdaa6db528565a666a1d0a85e7e02f9994222
IEDL.DBID 7X8
ISICitedReferencesCount 67
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000375541100018&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1527-7755
IngestDate Fri Sep 05 09:36:33 EDT 2025
Mon Jul 21 05:41:47 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 15
Language English
License 2016 by American Society of Clinical Oncology.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c299t-ad155330bf0d0977bbac08652f9ebdaa6db528565a666a1d0a85e7e02f9994222
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 27069078
PQID 1789034763
PQPubID 23479
ParticipantIDs proquest_miscellaneous_1789034763
pubmed_primary_27069078
PublicationCentury 2000
PublicationDate 2016-05-20
20160520
PublicationDateYYYYMMDD 2016-05-20
PublicationDate_xml – month: 05
  year: 2016
  text: 2016-05-20
  day: 20
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of clinical oncology
PublicationTitleAlternate J Clin Oncol
PublicationYear 2016
SSID ssj0014835
Score 2.4789662
Snippet American Society of Clinical Oncology (ASCO), the leading medical professional oncology society, is committed to lessening the burden of cancer and as such...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 1803
SubjectTerms Female
Humans
Medical Oncology
Papillomavirus Vaccines - adverse effects
Papillomavirus Vaccines - immunology
Physician's Role
Societies, Medical
Uterine Cervical Neoplasms - prevention & control
Vaccination
Title American Society of Clinical Oncology Statement: Human Papillomavirus Vaccination for Cancer Prevention
URI https://www.ncbi.nlm.nih.gov/pubmed/27069078
https://www.proquest.com/docview/1789034763
Volume 34
WOSCitedRecordID wos000375541100018&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFA7qRHzxMm_zRgTZk3W9pE3ri8hwiLitD1P2VtI0kcFs57oN9u89aVP6JAi-pA9taUm-5Hw538k5CN1Kx7GFJ5lB4iA2CJgMI3Akh4ZTRwrHd2WRXf-NDgb-eByE2uGW67DKak0sFuok48pH3rHUiU2HwHR4nH0bqmqUUld1CY1N1HCAyqiQLjquVQTiFwU2VeVWYJGuq2VKAEbntTtUcV3evUfVlfxOMAtD09v_7y8eoD1NMfFTiYlDtCHSJtrpaxG9idphma56fYdH9emr_A63cVgnsl4foc9KzsE6thNnEutEolM8TMvncMFXlZPxAReSAA7ZbDKdZl9sNZkvc_zBOHy4QAAGioy7CmhzXCWPytJj9N57HnVfDF2YweBgvRYGS1S1IceMpZmYQCDjmHHYGrm2DEScMOYlsWv7QBUZbI6YlZjMdwUVJtwPAuVzOkFbaZaKM4Qtj0lP-CQGnkcogxFjxOJSUjPgnPpWC91UfR0B8JWawVKRLfOo7u0WOi0HLJqVGToim6oEzNQ__8PbF2hXAUFFBNjmJWpImPbiCm3z1WKSz68LREE7CPs_V2vWaA
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=American+Society+of+Clinical+Oncology+Statement%3A+Human+Papillomavirus+Vaccination+for+Cancer+Prevention&rft.jtitle=Journal+of+clinical+oncology&rft.au=Bailey%2C+Howard+H&rft.au=Chuang%2C+Linus+T&rft.au=duPont%2C+Nefertiti+C&rft.au=Eng%2C+Cathy&rft.date=2016-05-20&rft.issn=1527-7755&rft.eissn=1527-7755&rft.volume=34&rft.issue=15&rft.spage=1803&rft_id=info:doi/10.1200%2FJCO.2016.67.2014&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1527-7755&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1527-7755&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1527-7755&client=summon